PT  - JOURNAL ARTICLE
AU  - Jaswaney, Rahul
AU  - Sokoloff, Samantha
AU  - Rakita, Val
AU  - Rubin, Daniel J.
TI  - SGLT-2 inhibitors in heart failure and chronic kidney disease: A review for internists
AID  - 10.3949/ccjm.91a.23093
DP  - 2024 Jul 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 415--423
VI  - 91
IP  - 7
4099  - http://www.ccjm.org/content/91/7/415.short
4100  - http://www.ccjm.org/content/91/7/415.full
SO  - Cleve Clin J Med2024 Jul 01; 91
AB  - Despite current therapies, heart failure and chronic kidney disease continue to be major causes of morbidity and mortality. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors have recently become standard-of-care therapy for these conditions. This review summarizes important randomized controlled trials of SGLT-2 inhibitors and guidelines for using these agents in patients with heart failure and chronic kidney disease in both clinic and hospital settings.